Enhancement of production of glycoalkaloids by elicitors along with characterization of gene expression of pathways in Solanum xanthocarpum.
J Biotechnol
; 391: 81-91, 2024 Aug 10.
Article
en En
| MEDLINE
| ID: mdl-38825191
ABSTRACT
Solanum xanthocarpum fruits are used in the treatment of cough, fever, and heart disorders. It possesses antipyretic, hypotensive, antiasthmatic, aphrodisiac and antianaphylactic properties. In the present study, 24 elicitors (both biotic and abiotic) were used to enhance the production of glycoalkaloids in cell cultures of S. xanthocarpum. Four concentrations of elicitors were added into the MS culture medium. The maximum accumulation (5.56-fold higher than control) of demissidine was induced by sodium nitroprusside at 50â¯mM concentration whereas the highest growth of cell biomass (4.51-fold higher than control) stimulated by systemin at 30â¯mM concentration. A total of 17 genes of biosynthetic pathways of glycoalkaloids were characterized from the cells of S. xanthocarpum. The greater accumulation of demissidine was confirmed with the expression analysis of 11 key biosynthetic pathway enzymes e.g., acetoacetic-CoA thiolase, 3- hydroxy 3-methyl glutaryl synthase, ß-hydroxy ß-methylglutaryl CoA reductase, mevalonate kinase, farnesyl diphosphate synthase, squalene synthase, squalene epoxidase, squalene-2,3- epoxide cyclase, cycloartenol synthase, UDP-glucose solanidine glucosyltransferase and UDP-rhamnose solanidine rhamno-galactosyl transferase. The maximum expression levels of UDP-rhamnose solanidine rhamno-galactosyl transferase gene was recorded in this study.
Palabras clave
Texto completo:
1
Base de datos:
MEDLINE
Asunto principal:
Solanum
/
Vías Biosintéticas
Idioma:
En
Revista:
J Biotechnol
Asunto de la revista:
BIOTECNOLOGIA
Año:
2024
Tipo del documento:
Article